Overexpression of ras is an independent prognostic factor in colorectal adenocarcinoma

APMIS

Volumn 106, Issue 6, 1998, Pages 657-664

  Sun, Xiao Feng ^a   Ekberg, Hanna ^a   Zhang, Hong ^a   Carstensen, John M ^a   Nordenskjold B ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Colorectal adenocarcinoma; DNA ploidy; Prognosis; ras; S phase fraction

Indexed keywords

HEAT SHOCK PROTEIN; PROTEIN P53; RAS PROTEIN;

ADENOCARCINOMA; ANEUPLOIDY; ARTICLE; CANCER STAGING; CLINICAL TRIAL; COLORECTAL CARCINOMA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIPLOIDY; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; ONCOGENE RAS; PRIORITY JOURNAL; PROGNOSIS; TETRAPLOIDY;

EID: 0031854090     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1699-0463.1998.tb01396.x     Document Type: Article

References (28)

1. Armitage, P. & Berry, G.: Statistical methods in medical research. Blackwell, Oxford 1987.
2. Barbacid, M.: ras genes. Annu. Rev. Biochem. 56: 779-827, 1987.
3. Bell, S. M., Scott. N., Cross, D., Sagar, P., Lewis, F. A., Blair, G. E., Taylor, G. R., Dixon, M. F. & Quire, P.: Prognostic value of pS3 overexpression and c-Ki-ras gene mutation in colorectal cancer. Gastroenterology 104: 57-64, 1993.
4. Benhattar, J., Losi, L., Chauber, P., Givel, J.-C. & Costa, J.: Prognostic significance of K-ras mutations in colorectal carcinoma. Gastroenterology 104: 1044-1048, 1993.
5. Burmer, G. C. & Loeb, L. A.: Mutations in the KRAS2 oncogene during progressive stages of human colon carcinoma. Proc. Natl. Acad. Sci. USA 86: 2403-2407, 1989.
6. Burmer, G. C., Rabinovitch, P. S. & Loeb, L. A.: Analysis of c-Ki-ras mutations in human colon carcinoma by sorting, polymerase chain reaction, and DNA sequencing. Cancer Res. 49: 2141-2146, 1989.
7. Cox, D. R.: Regression models and life tables. J. R. Statist. Soc. B 34: 187-220, 1972.
8. Dix, B. R., Robbins, P., Soong, R., Jenner, D., House, A. K & Iacopetta, B. R.: The common molecular genetic alterations in Duke's B and C colorectal carcinomas are not short-term prognostic indicators of survival. Int. J. Cancer 59: 747-751, 1994.
9. Elnatan, J., Goh, H.-S. & Smith, D. R.: c-Ki-ras activation and the biological behaviour of proximal and distal colonic adenocarcinomas. Eur. J. Cancer 32A: 491-497, 1996.
10. ras in fresh primary and metastatic human colorectal tumors. Proc. Natl. Acad. Sci. USA 82: 1795-1799, 1985.
11. Giaretti, W., Monaco, R., Pujic, N., Rapallo, A., Nigro, S. & Geido, E.: Intratumor heterogeneity of K-ras2 mutations in colorectal adenocarcinomas; Association with degree of DNA aneuploidy. Am. J. Pathol, 149: 237-245, 1996.
12. Kaplan, E. & Meier, P.: Nonparametric estimation from incomplete observations. J. Am. Statist. Assoc. 53: 457-481, 1958.
13. Kern, S. E., Fearon, E. R., Tersmette, K. W. F., Enterline, J. P., Leppert, M., Nakamura, Y. et al.: Clinical and pathological associations with allelic loss in colorectal carcinoma. JAMA 267: 3099-3103, 1989.
14. Laurent-Puig, P., Olschwang, S., Delattre, O., Remvikos, Y., Asselain, B., Melot, T., Validire, P., Muleris, M., Girodet, J., Salmon, R. J. & Thomas, G.: Survival and acquired genetic alterations in colorectal cancer. Gastroenterology 102: 1136-1141, 1992.
15. Losi, L., Benhattar, J. & Costa, J.: Stability of K-ras mutations throughout the natural history of human colorectal cancer. Eur. J. Cancer 28A: 1115-1120, 1992.
16. Miyahara, M., Saito, T., Kaketani, K. S., Sato, K., Kuwahara, A., Shimoda, K. & Kobayashi, M.: Clinical significance of ras p21 overexpression for patients with an advanced colorectal cancer. Dis. Colon Rectum 34: 1097-1102, 1991.
17. Nicolson, G. I.: Tumor oncogene expression and the metastatic phenotype. Cancer Res. 3: 25-57, 1986.
18. Nowell, P. C.: The clonal evolution of tumor cell populations. Science 194: 23-28, 1976.
19. Oudejans, J., Slebos, R. J. C., Zoetmulder, F. A. N., Mool, W. J. & Rodenhuis, S.: Differential activation of ras genes by point mutation in human colon cancer with metastases to either lung or liver. Int. J. Cancer 49: 875-879, 1991.
20. Shackney, S. E., Smith, C. A., Miller, B. W., Burholt, D. R., Murtha, K., Giles, H. R., Ketterer, D. M. & Pollice, A. A.: Model for the genetic evolution of human solid tumors. Cancer Res. 49: 3344-3354, 1989.
21. Shih, T. Y. & Weeks, M. O.: Oncogenes and cancer: The p21 ras gene. Cancer Invest. 2: 109-123, 1984.
22. Span, M., Moerkerk, P. T. M., De Goeij, A. F. P. M. & Arends, J. W.: A detailed analysis of K-ras point mutations in relation to tumor progression and survival in colorectal cancer patients. Int. J. Cancer 69: 241-245, 1996.
23. Suchy, B., Zietz, C. & Rabes, H. M.: K-ras point mutations in human colorectal carcinomas: relation to aneuploidy and metastasis. Int. J. Cancer 52: 30-33, 1992.
24. Sun, X.-F., Hatschek, T., Wingren, S., Stål, O., Carstensen, J., Zhang, H., Boeryd, B., Sjödahl, R. & Nordenskjöld, B.: ras p21 expression in relation to histopathological variables and prognosis in colorectal adenocarcinoma. Acta Oncol. 30: 933-939, 1991.
25. Sun, X.-F., Carstensen, J., Zhang, H., Stål, O., Wingren, S., Hatschek, T. & Nordenskjöld, B.: Prognostic significance of cytoplasmic p53 oncoprotein in colorectal adenocarcinoma. Lancet 340: 1369-1373, 1992.
26. Sun, X.-F., Carstensen, J., Stål, O., Wingren, S., Hatschek, T., Zhang, H. & Nordenskjöld, B.: Prognostic significance of DNA ploidy and S-phase fraction in colorectal adenocarcinoma. Diagn. Oncol. 3: 121-126, 1993.
27. Sun, X.-F., Zhang, H., Carstensen, J., Jansson, A. & Nordenskjöld, B.: Heat shock protein 72/73 in relation to cytoplasmic p53 expression and prognosis in colorectal adenocarcinomas. Int. J. Cancer 74: 600-604, 1997.
28. Yokota, J., Ookawa, K., Nishikawa, R. & Sameshima, Y.: Tumor suppressor genes involved in metastasis of lung and colorectal carcinomas. In: Harris, C. C. et al. (Eds.): Multistage carcinogenesis. Japan Sci. Soc. Press, Tokyo/CRC Press, Boca Raton 1992, pp. 71-76.